Company / Capital Returned to Shareholders
STAAR Surgical Company Capital Returned to Shareholders History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$6.5M
FY2025
5-year range
$6.5M / $6.5M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#91 of 108
Health Care
What the data says
STAAR Surgical Company's capital returned to shareholders of $6M is lower than 84% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$6M in FY2025.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 108This company $6.5M Sector average $754.9M
▼
-99.1% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.5M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026